Skin appendage disorder

This study tested a drug called amlitelimab in 166 adults with severe alopecia areata, a condition causing significant hair loss. Participants received either the drug or a placebo by injection. The main goal was to see if the drug could reduce hair loss scores after 36 weeks. Th…

This study tested whether exosomes from donated stem cells could help people with hair loss. It was a small, early-phase trial with 16 participants, comparing treated areas to untreated ones. The study was terminated early, so results are limited. The goal was to see if the treat…

This study tested a drug called KL130008 in 114 adults with severe alopecia areata, a condition causing major hair loss. The goal was to see if the drug could safely regrow hair, measured by how many people achieved 80% or more scalp coverage. However, the trial was terminated ea…

This study tested a custom ointment called DPCP to help people with severe alopecia areata, a condition causing patchy or complete scalp hair loss. The goal was to see if the ointment could safely regrow hair. Only 4 people took part before the study was stopped early, so results…

This study tested whether intense pulsed light (IPL) can help treat chalazion, a common eyelid lump. Only 4 adults with a fresh chalazion were enrolled, and the trial was stopped early. Because of the very small size, we cannot say if IPL works or is safe for this condition.

This study tested a WaterPik-like device to massage and clean the scalp in people with dandruff, seborrheic dermatitis, or hair loss. Only 2 people took part before the study was stopped early. The goal was to see if the device could reduce flaking and redness.

This study tested whether a laser treatment used for skin rejuvenation could help grow hair in people with alopecia (hair loss) on the scalp. Only 5 people were enrolled before the study was stopped early. Each person had half their scalp treated with a laser and the other half l…

This study tested a dietary supplement made from plant extracts to see if it could help men aged 40 to 65 with thinning hair. The trial was planned to last 9 months and involved 155 men, but it was terminated early. Researchers aimed to measure hair growth and quality compared to…